As previously reported, we also found ART558 to be effective in decreasing cell viability and colony formation in DLD1 colorectal adenocarcinoma cells with a truncating mutation in BRCA2 compared with isogenic WT DLD1 cells (Supplemental Figure 3, A and B). The gene discussed is BRCA2; the disease is colorectal adenocarcinoma.